Drugs for Cleft Lip/palate (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 39)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Rocuronium |
Approved |
Phase 4 |
|
119302-91-9, 143558-00-3 |
441290 |
Synonyms:
1-(17-(Acetoyl)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)pyrrolidinium
Esmeron
Esmerone
ORG-9426
Pyrrolidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-17-(acetyloxy)-3-hydroxy-2-(4-morpholinyl)androstan-16-yl)-1-(2-propenyl)-, bromide
|
Rocuronio
ROCURONIUM
Rocuronium bromide
Zemuron
|
|
2 |
|
Dexmedetomidine |
Approved, Experimental, Vet_approved |
Phase 4 |
|
86347-14-0, 113775-47-6 |
68602 5311068 |
Synonyms:
(+)-4-((S)-a,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-Α,2,3-trimethylbenzyl)imidazole
(+-)-4-(a,2,3-Trimethylbenzyl)imidazole
(+-)-4-(alpha,2,3-Trimethylbenzyl)imidazole
(+-)-4-(Α,2,3-trimethylbenzyl)imidazole
(+)-MEDETOMIDINE
(±)-4-(α,2,3-trimethylbenzyl)imidazole
(S)-MEDETOMIDINE
Dexdor
Dexdor®|Igalmi® (dexmedetomidine sublingual film)|MPV 1440|Precedex®
DEXMEDETOMIDIN
Dexmedetomidina
DEXMEDETOMIDINE
DEXMÉDÉTOMIDINE
Dexmedetomidine hydrochloride
Dexmedetomidinum
|
Domitor
Hospira brand OF dexmedetomidine hydrochloride
Hydrochloride, dexmedetomidine
Hydrochloride, medetomidine
Levomedetomidine
Medetomidina
Medetomidina [Spanish]
Medetomidine
Medetomidine hydrochloride
Medetomidinum
Medetomidinum [Latin]
MPV 1440
MPV 785
MPV-1440
MPV-785
Precedex
|
|
3 |
|
Ketamine |
Approved, Vet_approved |
Phase 4 |
|
6740-88-1, 1867-66-9 |
3821 |
Synonyms:
(-)-Ketamine
(+-)-Ketamine
(±)-ketamine
(S)-(-)-Ketamine
(S)-Ketamine
2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone
2-(2-Chloro-phenyl)-2-methylamino-cyclohexanone
2-(Methylamino)-2-(2-chlorophenyl)cyclohexanone
2-(O-Chlorophenyl)-2-(methylamino)-cyclohexanone
Calipsol
Calypsol
CI 581 base
CLSTA 20
DL-Ketamine
Esketamine
Kalipsol
Ketaject
Ketalar
|
Ketalar base
Ketalar|ketamine HCl
Ketamina
KETAMINE
Kétamine
Ketamine base
Ketamine HCL
Ketamine hydrochloride
Ketaminum
Ketanest
Ketaset
Ketolar
L-Ketamine
NMDA
NSC-70151
Special K
Tekam
|
|
4 |
|
Sevoflurane |
Approved, Vet_approved |
Phase 4 |
|
28523-86-6 |
5206 |
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
Fluoromethyl hexafluoroisopropyl ether
Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
HFE-347MMZ1
MR6S4
MR-6S4
Sevofluran
SEVOFLURANE
|
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevorane
SOJOURN
Ultane
|
|
5 |
|
Remifentanil |
Approved |
Phase 4 |
|
132875-61-7 |
60815 |
Synonyms:
3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
GI 87084X
GI-87084B
IDS-NR-005
Remifentanil
|
Remifentanil hydrochloride
Remifentanil monohydrochloride
Remifentanilo
Remifentanyl
Ultiva
|
|
6 |
|
Propofol |
Approved, Investigational, Vet_approved |
Phase 4 |
|
2078-54-8 |
4943 |
Synonyms:
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Diisopropylphenol
2,6-diisopropylphenol|Diprivan®|ICI 35868
Abbott brand OF propofol
Alpha Brand OF propofol
Aquafol
Astra brand OF propofol
AstraZeneca brand OF propofol
Braun brand OF propofol
Curamed brand OF propofol
Diisopropylphenol
Diprivan
Disoprivan
Disoprofol
Fresenius brand OF propofol
Fresenius kabi brand OF propofol
Fresofol
ICI 35868
ICI 35-868
|
ICI35,868
ICI-35868
Ivofol
Juste brand OF propofol
NSC-5105
Parnell brand OF propofol
Pisa brand OF propofol
Propofol
Propofol abbott
Propofol fresenius
Propofol MCT
Propofol rovi
Propofol-lipuro
Propofolum
Rapinovet
Recofol
Rovi brand OF propofol
Schering brand OF propofol
Zeneca brand OF propofol
|
|
7 |
|
Methylene blue |
Approved, Investigational |
Phase 4 |
|
61-73-4 |
6099 |
Synonyms:
3,7-BIS(DIMETHYLAMINO)PHENAZATHIONIUM CHLORIDE
aniline violet
Azul de metileno
BASIC BLUE 9
C.I. 52015
C.I. BASIC BLUE 9
Chlorure de méthylthioninium
CI 52015
CI-52015
Cloruro de metiltioninio
EHRLICH'S REAGENT III
LOWACRYL BLUE 9
METHYLENE BLUE
METHYLENE BLUE ANHYDROUS
METHYLENE BLUE TRIHYDRATE
|
METHYLENIUM CERULEUM
METHYLTHIONINE CHLORIDE
METHYLTHIONINE HCL
Methylthioninii chloridum
METHYLTHIONINIUM CHLORIDE
methylthioninium chloride Proveblue
NSC-215213
NSC-617593
PROVAYBLUE
SOLVENT BLUE 8
SWISS BLUE
tetrametylthionine chloride
TRX0014
UROLENE BLUE
VIB100
|
|
8 |
|
Clindamycin |
Approved, Vet_approved |
Phase 4 |
|
18323-44-9, 24729-96-2 |
29029 |
Synonyms:
7 Chloro 7 deoxylincomycin
7(S)-Chloro-7-deoxylincomycin
7-CDL
7-Chloro-7-deoxylincomycin
ANTIROBE
Chlolincocin
Chlorlincocin
CHLORODEOXYLINCOMYCIN
CHLOROLINCOMYCIN
CLDM
Cleocin
Cleocin Hcl
Cleocin Pediatric
Cleocin Phosphate
CLEOCIN T
Cleocin T Gel
Cleocin T Lotion
Cleocin T Topical Solution
Clinda-Derm
Clindagel
Clindamicina
Clindamicina [INN-Spanish]
CLINDAMYCIN
Clindamycin Hcl
Clindamycin hydrochloride
Clindamycin monohydrochloride
Clindamycin monohydrochloride, monohydrate
|
Clindamycin phosphate
Clindamycine
Clindamycine [French]
Clindamycine [INN-French]
Clindamycinum
Clindamycinum [INN-Latin]
Clindesse
Clindets
Clinimycin
Dalacin
Dalacin C
Dalacin C Flavored Granules
Dalacin C Phosphate
Dalacin T Topical Solution
Evoclin
Hydrochloride, clindamycin
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-a-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside
Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside
Monohydrate clindamycin monohydrochloride
Monohydrochloride, clindamycin
Monohydrochloride, monohydrate clindamycin
ResiDerm A
SOBELIN
U-21251
Zindaclin
|
|
9 |
|
Ketorolac |
Approved |
Phase 4 |
|
74103-06-3, 66635-83-4 |
3826 |
Synonyms:
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate
(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid
(+-)-Ketorolac
ACULAR
Acular LS
Acular Preservative Free
Acular®|Toradol®
Ketoralac
Ketorolac
|
Kétorolac
Ketorolac tromethamine
Ketorolaco
Ketorolaco [Spanish]
Ketorolacum
Ketorolacum [Latin]
rac-Ketorolac
Toradol
|
|
10 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
11 |
|
Adrenergic alpha-Agonists |
|
Phase 4 |
|
|
|
12 |
|
Adrenergic Agonists |
|
Phase 4 |
|
|
|
13 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
14 |
|
Excitatory Amino Acid Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Anesthetics, Dissociative |
|
Phase 4 |
|
|
|
16 |
|
Hypnotics and Sedatives |
|
Phase 4 |
|
|
|
17 |
|
Analgesics |
|
Phase 4 |
|
|
|
18 |
|
Anesthetics |
|
Phase 4 |
|
|
|
19 |
|
Analgesics, Non-Narcotic |
|
Phase 4 |
|
|
|
20 |
|
Anti-Bacterial Agents |
|
Phase 4 |
|
|
|
21 |
|
Fibrin Tissue Adhesive |
|
Phase 4 |
|
|
|
22 |
|
Penicillins |
|
Phase 4 |
|
|
|
23 |
|
Antibiotics, Antitubercular |
|
Phase 4 |
|
|
|
24 |
|
Hemostatics |
|
Phase 4 |
|
|
|
25 |
|
Clindamycin phosphate |
|
Phase 4 |
|
|
32603 |
Synonyms:
Cleocin phosphate
Clindamycin phosphoric acid
Clindamycin-2-phosphate
|
|
|
26 |
|
Clindamycin palmitate |
|
Phase 4 |
|
|
|
27 |
|
Antirheumatic Agents |
|
Phase 4 |
|
|
|
28 |
|
Cyclooxygenase Inhibitors |
|
Phase 4 |
|
|
|
29 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 4 |
|
|
|
30 |
|
Anti-Inflammatory Agents |
|
Phase 4 |
|
|
|
31 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
|
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
32 |
|
Morphine |
Approved, Investigational |
|
|
57-27-2 |
5288826 |
Synonyms:
(-)-Heroin hydrochloride
(-)-Morphine
(−)-MORPHINE
(5a,6a)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5a,6a)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5Α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5Α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
ANHYDROUS MORPHINE
Apokyn
Astramorph PF
AVINZA
Chloride, morphine
Contin, MS
D-(-)-Morphine
DEPODUR
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dulcontin
Duramorph
Duramorph PF
Duromorph
Epimorph
Heroin hydrochloride
Heroine hydrochloride
IDS-NM-009
INFUMORPH
KADIAN
l-Morphine
M.O.S
Meconium
M-Eslon
Morfina
Morfina dosa
|
Morphia
Morphin
Morphina
MORPHINE
Morphine chloride
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine sulfate
Morphine sulfate (2:1), anhydrous
Morphine sulfate (2:1), pentahydrate
morphine sulfate|Ms Contin®|Oramorph®
Morphinism
Morphinum
Morphitec
Morphium
Moscontin
MS Contin
MS/L
MS/S
MSIR
N02AA01
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
ORAMORPH
Oramorph SR
Ospalivina
Rescudose
RMS Uniserts
Roxanol
Roxanol 100
Roxanol UD
Statex
Statex Drops
Substitol
Sulfate, morphine
|
|
33 |
|
Anesthetics, Intravenous |
|
|
|
|
|
34 |
|
Anesthetics, General |
|
|
|
|
|
35 |
|
Analgesics, Opioid |
|
|
|
|
|
36 |
|
Narcotics |
|
|
|
|
|
37 |
|
Daminozide |
|
|
|
1596-84-5 |
15331 |
Synonyms:
Alar
Alar-85
B 995|DMASA|SADH
b9 Regulator
|
N-(dimethylamino)Succinamate
N-(dimethylamino)Succinamic acid
Succinic acid, 2,2-dimethyl hydrazide
|
|
38 |
|
Calcium, Dietary |
|
|
|
|
|
39 |
|
Calcium |
Nutraceutical |
|
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
Interventional clinical trials:
(show top 50)
(show all 71)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Opioid Free Anaesthesia vs Opioid Based Anesthesia in Cleft Lip, Palate ,Alveolus Surgery. |
Unknown status |
NCT04081909 |
Phase 4 |
Fentanyl,Remifentanil;Ketamine,Dexmedetomidine |
2 |
Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate: A Randomized Clinical Trial |
Recruiting |
NCT04234971 |
Phase 4 |
Intervention group (DBM/BMP);Control group(autologous ICBG) |
3 |
Ketorolac in Palatoplasty: A Randomized Blinded Controlled Trial. |
Recruiting |
NCT04771156 |
Phase 4 |
Ketorolac;Placebo |
4 |
Bone Tissue Engineering With Dental Pulp Stem Cells for Alveolar Cleft Repair |
Completed |
NCT03766217 |
Phase 3 |
|
5 |
Distraction Versus Orthognathic Surgery - Which One is Better for Cleft Palate Patients |
Completed |
NCT00930124 |
Phase 2 |
|
6 |
Parent's Satisfaction and Evaluation of Postsurgical Outcomes in Unilateral Cleft Lip / Palate Newly Born Infants With / Without Vacuum Formed Nasoalveolar Molding Aligners : A Controlled Clinical Trial |
Unknown status |
NCT03011489 |
|
|
7 |
Stability of One-Piece Le Fort I Osteotomy Versus Segmental Le Fort I Osteotomy: A Prospective Study |
Unknown status |
NCT01871623 |
|
|
8 |
Three-dimensional Development of the Palate in Bilateral Orofacial Cleft Newborns One Year After Early Neonatal Cheiloplasty: Classic and Geometric Morphometric Evaluation |
Unknown status |
NCT03839290 |
|
|
9 |
Microimplant-assisted Rapid Palatal Expansion Appliance to Orthopedically Correct Midface Deficiency in Patients With Cleft Lip and Palate: a Randomized Clinical Trial |
Unknown status |
NCT04354116 |
|
|
10 |
Transverse Dento-skeletal Effects of Two Rapid Palatal Expansion Appliances in Cleft Lip and Palate Patients : A Randomized Clinical Trial |
Unknown status |
NCT04236466 |
|
|
11 |
Distribution Of ABO Blood Groups In Relation To Cleft Lip And/or Palate . |
Unknown status |
NCT03217890 |
|
|
12 |
Evaluation of Arch Dimensions of Children With Surgically Repaired Unilateral Cleft Lip and Palate: A Cross Sectional Study |
Unknown status |
NCT03219021 |
|
|
13 |
Osteogenesis and Dental Eruption Through Electrical Stimuli Following Periosteoplasty for Alveolar Clefts in Patients With Cleft Lip and Palate Deformities. A Preliminary Report. |
Unknown status |
NCT00975208 |
|
|
14 |
The Difference in the Surgical Outcome of Unilateral Cleft Lip and Palate Between Patients With and Without Pre-Alveolar Bone Graft Orthodontic Treatment |
Unknown status |
NCT02454998 |
|
|
15 |
OSAS in Children With Cleft Lip/Palate |
Completed |
NCT00156442 |
|
|
16 |
Efficacy of Nasoalveolar Molding Therapy for Treatment of Unilateral Cleft Lip and Palate in Egyptian Infants |
Completed |
NCT03029195 |
|
|
17 |
Effectiveness of Nasal-alar Elevator (NE) Combined With Taping Vs. Taping Alone on Improving the Nose Esthetics and Maxillary Arch Dimensions in Infants With Unilateral Complete Cleft Lip and Palate: A Randomized Clinical Trial |
Completed |
NCT04331379 |
|
|
18 |
Use of Mesenchymal Stem Cells for Alveolar Bone Tissue Engineering for Cleft Lip and Palate Patients |
Completed |
NCT01932164 |
|
|
19 |
The Effect of a Newly Designed Presurgical Orthopedic Appliance on Maxillary Arch Dimensions in Infants With Bilateral Cleft Lip and Palate: Randomized Clinical Trial |
Completed |
NCT05535530 |
|
|
20 |
Electromyographic Analysis of the Masticatory Muscles in Cleft Lip and Palate Children With Pain-related Temporomandibular Disorders |
Completed |
NCT03308266 |
|
|
21 |
Periodontal Changes and Gingival Soft Tissue Healing Following Mid Maxillary Distraction in Cleft Lip and Palate Patients |
Completed |
NCT03686761 |
|
|
22 |
Comparison of Cleft Lip and Palate Between a United States Tertiary Care Center and a Guatemalan Surgical Mission: A Cohort Study of 629 Pediatric Patients and a Survey of Risk Factors |
Completed |
NCT04725370 |
|
|
23 |
Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate |
Completed |
NCT02789787 |
|
|
24 |
Unilateral Cleft Repair in One Surgery With Pure Primary Healing |
Completed |
NCT04108416 |
|
|
25 |
Otologic and Rhinologic Outcomes in Children With Cleft Palate at Age 10 Years |
Completed |
NCT03708406 |
|
|
26 |
Ultrasound Diagnosis of Cleft Lip and Palate - FENCHU |
Completed |
NCT03582111 |
|
|
27 |
Functional Outcomes of Cleft Lip and Lip Revision Surgery |
Completed |
NCT00070811 |
|
|
28 |
Efficacia Del Trattamento Chirurgico Maxillo-facciale Sul Volto Dei Bambini Con Labiopalatoschisi: Valutazioni Estetiche ed Ortodontiche |
Completed |
NCT03395015 |
|
|
29 |
Clinical, Volumetric and Densitometric Evaluation of Tissue Engineered (TE) Constructs for Secondary Alveolar Cleft Reconstruction (Short Term Randomized Controlled Clinical Trial) |
Completed |
NCT03563495 |
|
|
30 |
Evaluation of Facial Growth in Two Primary Protocols Used in the Surgical Treatment of Unilateral Cleft Lip and Palate Patients. A Prospective Randomized Trial |
Completed |
NCT02329509 |
|
|
31 |
Three Dimensional Changes on Nasal Septum and Alveolar Cleft After Maxillary Expansion: A Case Series |
Completed |
NCT03976609 |
|
|
32 |
Effect of A Novel (Modified Grayson) Technique for Nasoalveolar Molding and Taping on Parents' Satisfaction and Short Term Treatment Outcomes in Infants With Unilateral Complete Cleft Lip and Palate: A Randomized Controlled Trial |
Completed |
NCT02845193 |
|
|
33 |
Correlation Between Body Mass Index and Progressive Bone Mineral Density in Cleft Patients After Secondary Alveolar Bone Grafting |
Completed |
NCT05002920 |
|
|
34 |
Evaluation of the Clinical Effectiveness of Naso-alveolar Molding (NAM) Versus Computer Aided Design NAM (CAD/NAM) in Infants With Bilateral Cleft Lip and Palate: A Randomized Clinical Trial |
Completed |
NCT02881606 |
|
|
35 |
Progressive Comparison of Density Assessment of Alveolar Bone Graft in Patients With Unilateral and Bilateral Cleft |
Completed |
NCT04987190 |
|
|
36 |
Articulatory and Phonological Competence at 3 and 5 Years of Age in Children With Unilateral Cleft Lip and Palate Who Have Undergone Different Methods of Primary Palatal Surgery |
Completed |
NCT00829101 |
|
|
37 |
Emergence Delirium and Recovery Profile in Patients Undergoing Cleft Lip and Palate Repair: Comparison of Combination of Morphine and Fentanyl With Fentanyl Alone |
Completed |
NCT03010540 |
|
MORPHINE PLUS FENTANYL;Fentanyl |
38 |
The Effect of the Usage of Squeezable vs Standard Bottles on the Feeding Process of Infants With Cleft Lip and Palate (CLP) After Cleft Palate Surgery |
Completed |
NCT05062798 |
|
|
39 |
Effect of Alveolar Bone Grafting on Health Quality in Patients With Cleft Lip and Palate |
Completed |
NCT03549039 |
|
|
40 |
Follow Ups of Parents With Infants With Cleft Lip and Palate |
Completed |
NCT02415361 |
|
|
41 |
Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate: a Prospective, Randomized, Clinical Trial |
Recruiting |
NCT05081258 |
|
|
42 |
Short Term Efficiency of Presurgical Vacuum Formed Nasoalveolar Molding Aligners in Infants With Bilateral Cleft Lip and Palate Compared With Conventional Grayson Acrylic Formed Nasoalveolar Molding Appliances: A Randomized Clinical Trial |
Recruiting |
NCT04966572 |
|
|
43 |
Collaborative, Comparative Study on Three-dimensional Cleft Lip and Palate Morphology Prior to One-stage Cleft Repair (Warsaw/Basel) |
Recruiting |
NCT04616690 |
|
|
44 |
Identification of Genetic Factors Implicated in Orofacial Cleft Using Whole Exome Sequencing GENEPIC |
Recruiting |
NCT03065686 |
|
|
45 |
Effectiveness of Two Rapid Maxillary Expanders (Quadhelix vs Hyrax) in Improving the Transverse Skeletal and Dental Dimensions in Patients With Cleft Lip and Palate: A Randomized Clinical Trial |
Recruiting |
NCT04331977 |
|
|
46 |
Does an Audio-visual Aid Reduce Anxiety and Improve the Understanding of Children Undergoing an Alveolar Bone Graft: Randomised Control Trial |
Recruiting |
NCT04381078 |
|
|
47 |
Augmented Reality (AR): The Future of "Patient Information Leaflets |
Recruiting |
NCT04619030 |
|
|
48 |
Evaluation of Dental Age of Children With Cleft Lip and Palate Using Willems Method, Cameriere European Formula, and London Atlas |
Recruiting |
NCT05573295 |
|
|
49 |
Intraoperative Assessment of the Influence of Cleft Repair on Microcirculation of the Palate |
Recruiting |
NCT03877666 |
|
|
50 |
Simplifying Home Weight Monitoring for Infants With Cleft Lip and/or Palate Differences to Determine if Use of an In-home Scale Leads to Better Compliance With Weight Monitoring Recommendations |
Recruiting |
NCT04384276 |
|
|
|